10x Genomics TXG
NASDAQ TXG
$71.46 +1.57 (+2.25%)
At close: Oct 20, 2026 · 4:00 PM EDT

10x Genomics (TXG) Gains from Investment Securities (2023 - 2024)

Updated

Analysis

10x Genomics (TXG) Gains from Investment Securities (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 254.87 Bn 233.89 Bn 4.88 Bn
2 Abbott Laboratories 178.85 Bn 149.28 Bn 7.27 Bn
3 Danaher 158.49 Bn 142.30 Bn 3.61 Bn
4 Intuitive Surgical 154.99 Bn 134.41 Bn 1.96 Bn
5 Medtronic 121.02 Bn 86.28 Bn 6.34 Bn
6 Stryker 116.94 Bn 103.05 Bn 4.50 Bn
7 Boston Scientific 66.98 Bn 61.75 Bn 3.85 Bn
8 Becton Dickinson 53.23 Bn 50.38 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 10x Genomics 9.28 Bn 9.08 Bn 112.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -2,000.00
Jun 30, 2024 -1,000.00
Dec 31, 2023 -3,000.00
Mar 31, 2023 -1.72 Mn
API Access

10x Genomics Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=TXG&period=max&api_key=YOUR_API_KEY